NEWSFLOW
MaxCyte (#MXCT) – “signing of strategic platform license”, no financial specifics
- 2023-01-04 07:29:57
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares
Results: MXCT
Search articles by EPIC code
NEWSFLOW
MaxCyte (#MXCT) – submitted Nasdaq dual-listing and shares offering draft registration statement
- 2021-05-14 07:57:07
views
MaxCyte Can ExCite the Medical World with its Promising Gene Therapy
Hello, Share Diviners. I’m never sure why American firms want to list on our AIM market, but MaxCyte (MXCT) looks worth a look. It’s a medical pioneer which uses cell therapy.
- By Malcolm Stacey
- 2019-05-30 08:18:50
NEWSFLOW
MaxCyte (#MXCT) – placing to raise a minimum of £10m at 170p per share, an 8% discount
- 2019-02-05 00:53:32
NEWSFLOW
Biotech outfit MaxCyte (#MXCT) joins AIM casino after placing at 70p. Good luck
- 2016-03-28 23:24:57
Page 1 of 1 (8 articles)
